| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8778486 | European Urology | 2018 | 11 Pages |
Abstract
Prostate cancer is a heterogeneous disease with a wide variability. Genomic biomarkers in combination with clinical and pathological variables are useful tools to reduce the number of unnecessary biopsies, stratify low-risk from high-risk tumors, and guide personalized treatment decisions.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Vito Cucchiara, Matthew R. Cooperberg, Marc Dall'Era, Daniel W. Lin, Francesco Montorsi, Jack A. Schalken, Christopher P. Evans,